Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

Jordan DELISLE
Jan 11, 2018
1 min read

Updated: Feb 13, 2020

M.A Postow, R. Sidlow, M.D Hellmann, 2018.

The wide range of immune-related adverse effects associated with immune checkpoint blockade can complicate this effective therapy and limit its use in patients with cancer. This review surveys the adverse effects and their management.

Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018). Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. The New England Journal of Medicine, 378(2), 158–168.

doi: 10.1056/NEJMra1703481

Recent Posts

See All

S. Jamal et al., 2020. Immune checkpoint inhibitors have revolutionized cancer therapy by blocking inhibitory pathways of the immune...

Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy

Kostine M et al., 2019 Compared with conventional cancer therapies, the spectrum of toxicities observed with checkpoint inhibitors is...

Testing Immune-Related Adverse Events in Cancer Immunotherapy

JR. Farmer, 2019. Immune-targeted therapeutics are being used in cancer. Immune "checkpoint inhibition" provides promise for prolonged...

Comments